Figure 5 shows the levels of the three genes HIST2H2AA3, LUZP6 and HLA-DRA across the disease stages. None of the three was significantly associated with the disease stage in pancreatic cancer (p > 0.05). This evidence concerns the gene HLA-DRA and familial pancreatic carcinoma.